OJEM  Vol.10 No.1 , March 2022
Out of Sight, Out of Mind, Right? Not in COVID-19 Shock or Anaerobic and Exhaustive Shock versus Septic Shock Dilemma That Means to Live or Die. Emergency Attention and a Necessity of Trials
Abstract: Background: COVID-19 brought challenges that did not end after a two-year pandemic. From more straightforward changes in habits to studying to understand the enigmatic parasite-host relationship, we can better manage the patient infected with SARS-CoV-2 even with a vaccine full of doubts and antivirals that do not correctly cover the viral period. SARS-CoV-2 brought the chronic inflammation now called “The Long COVID-19 Syndrome” (LCS), something still little talked about, but we already see deaths due to non-identification of this inflammatory syndrome that can lead to shock. Theory: LCS Shock is due to a long period of metabolic stress, reflecting the shift from inflammation to oxidative stress and innate immunity, and does not respond to antimicrobials, as its main component is inflammatory, although there may be conjoined bacterial translocation. Thus, we are losing patients to a new syndrome confused with sepsis and septic shock. While septic shock (SS) responds to antimicrobials, Inflammatory Shock (ISc) does not respond to antimicrobials alone, requiring high doses of corticosteroids. Review: This study shows that we need to differentiate SS and ISC, as the treatment is different. The review shows that Lactate, LDH and the presence of new/recent cardiac changes and bradycardia in the face of a status where there should be tachycardia as the usual response can differ ISC from SS. Maybe the main responsible for high LDH is Warburg Effect. Conclusion: We have a dilemma that requires clinical studies that routinely match high doses of corticosteroids (until there is something better to be done) and bring laboratory and imaging differences to diagnose SS vs ISc better.
Cite this paper: Zanella, L. , (2022) Out of Sight, Out of Mind, Right? Not in COVID-19 Shock or Anaerobic and Exhaustive Shock versus Septic Shock Dilemma That Means to Live or Die. Emergency Attention and a Necessity of Trials. Open Journal of Emergency Medicine, 10, 19-47. doi: 10.4236/ojem.2022.101003.

[1]   Patel, P., Decuir, J., Abrams, J., Campbell, A.P., Godfred-Cato, S. and Belay, E.D. (2021) Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults a Systematic Review. JAMA Network Open, 4, Article ID: 2126456.

[2]   Chow, E.J. (2021) The Multisystem Inflammatory Syndrome in Adults with SARS-CoV-2 Infection—Another Piece of an Expanding Puzzle. JAMA Network Open, 4, Article ID: e2110344.

[3]   Wang, Y., Yao, R., Zhang, L., Xie, X., Chen, R. and Ren, Z. (2019) IDO and intra-Tumoral Neutrophils Were Independent Prognostic Factors for Overall Survival for Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis, 33, Article ID: e22872.

[4]   Gasperi, V., Sibilano, M., Savini, I. and Catani, M.V. (2019) Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications. International Journal of Molecular Sciences, 20, Article No. 974.

[5]   Westbrook, R., Chung, T., Lovett, J., Ward, C., Joca, H., Yang, H., et al. (2020) Kynurenines Link Chronic Inflammation to Functional Decline and Physical Frailty. JCI Insight, 5, Article ID: e136091.

[6]   Favennec, M., Hennart, B., Caiazzo, R., Leloire, A., Yengo, L., Verbanck, M., et al. (2015) The Kynurenine Pathway Is Activated in Human Obesity and Shifted toward Kynurenine Monooxygenase Activation. Obesity, 23, 2066-2074.

[7]   Chen, L.-M., Bao, C.H., Wu, Y., Liang, S.H., Wang, D., Wu, L.Y., et al. (2021) Tryptophan-Kynurenine Metabolism: A Link between the Gut and Brain for Depression in Inflammatory Bowel Disease. Journal of Neuroinflammation, 18, Article No. 135.

[8]   Sakurai, M., Yamamoto, Y., Kanayama, N., Hasegawa, M., Mouri, A., Takemura, M., et al. (2020) Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the High Risk Subjects of Major Depressive Disorder. Scientific Reports, 10, Article No. 1961.

[9]   Vakhshoori, M., Heidarpour, M., Bondariyan, N., Sadeghpour, N. and Mousavi, Z. (2021) Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review. International Journal of Endocrinology, 2021, Article ID: 2271514.

[10]   Talaei, F., Bouma, H.R., van der Graaf, A.C., Strijkstra, A.M., Schmidt, M. and Henning, R.H. (2011) Serotonin and Dopamine Protect from Hypothermia/Rewarming Damage through the CBS/ H2S Pathway. PLoS ONE, 6, Article ID: e22568.

[11]   Zhou, H., Peng, X., Hu, J., Wang, L., Luo, H., Zhang, J., et al. (2021) DsbA-L Deficiency in T Cells Promotes Diet-Induced Thermogenesis through Suppressing IFN-γ Production. Nature Communications, 12, Article No. 326.

[12]   Thomas, T., Stefanoni, D., Reisz, J.A., Nemkov, T., Bertolone, L., Francis, R.O., et al. (2020) COVID-19 Infection Alters Kynurenine and Fatty Acid Metabolism, Correlating with IL-6 Levels and Renal Status. JCI Insight, 5, Article ID: e140327.

[13]   Page-Wilson, G., Arakawa, R., Nemeth, S., Bell, F., Girvin, Z., Tuohy, M.-C., et al. (2021) Obesity Is Independently Associated with Septic Shock, Renal Complications, and Mortality in a Multiracial Patient Cohort Hospitalized with COVID-19. PLoS ONE, 16, Article ID: e0255811.

[14]   Edalatifard, M., Akhtari, M., Salehi, M., Naderi, Z., Jamshidi, A., Mostafaei, S., et al. (2020) Intravenous Methylprednisolone Pulse as a Treatment for Hospitalised Severe Covid-19 Patients: Results from a Randomised Controlled Clinical Trial. European Respiratory Journal, 56, Article ID: 2002808.

[15]   de Assis Barros D’Elia Zanella, L., de Sá Paraskevopoulos, D., de Lima Galvão, L. and Yamaguti, A. (2021) Methylprednisolone Pulse Therapy in COVID-19 as the First Choice for Public Health: When Right Timing Breaks Controversies—Emergency Guide. Open Journal of Emergency Medicine, 9, 84-114.

[16]   Bruno, R.R., Wernly, B., Flaatten, H., Fjølner, J., Artigas, A., Bollen Pinto, B., et al. (2021) Lactate Is Associated with Mortality in Very Old Intensive Care Patients Suffering from COVID-19: Results from an International Observational Study of 2860 Patients. Annals of Intensive Care, 11.

[17]   Chau, V.Q., Giustino, G., Mahmood, K., Oliveros, E., Neibart, E., Oloomi, M., et al. (2020) Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males with COVID-19. Circulation: Heart Failure, 13, 556-559.

[18]   Arina, P., Moro, V., Baso, B., Baxter-Derrington, C. and Singer, M. (2021) Sepsis in Severe COVID-19 Is Rarely Septic Shock: A Retrospective Single-Centre Cohort Study. British Journal of Anaesthesia, 127, e182-e185.

[19]   Poston, J.T., Patel, B.K. and Davis, A.M. (2020) Management of Critically Ill Adults with COVID-19. JAMA, 323, 1839-1841.

[20]   Iepsen, U.W., Plovsing, R.R., Tjelle, K., Foss, N.B., Meyhoff, C.S., Ryrsø, C.K., et al. (2021) The Role of Lactate in Sepsis and COVID-19: Perspective from Contracting Skeletal Muscle Metabolism. Experimental Physiology.

[21]   Ibrahim, M.E., AL-Aklobi, O.S., Abomughaid, M.M. and Al-Ghamdi, M.A. (2021) Epidemiological, Clinical, and Laboratory Findings for Patients of Different Age Groups with Confirmed Coronavirus Disease 2019 (COVID-19) in a Hospital in Saudi Arabia. PLoS ONE, 16, Article ID: e0250955.

[22]   Nagy, C. and Haschemi, A. (2015) Time and Demand Are Two Critical Dimensions of Immunometabolism: The Process of Macrophage Activation and the Pentose Phosphate Pathway. Frontiers in Immunology, 6, Article No. 164.

[23]   Chen, X., Qian, Y. and Wu, S. (2015) The Warburg Effect: Evolving Interpretations of An Established Concept. Free Radical Biology and Medicine, 79, 253-263.

[24]   Jiang, P., Du, W. and Wu, M. (2014) Regulation of the Pentose Phosphate Pathway in Cancer. Protein & Cell, 5, 592-602.

[25]   Soto-Heredero, G., Gómez de Las Heras, M.M., Gabandé-Rodríguez, E., Oller, J. and Mittelbrunn, M. (2020) Glycolysis—A Key Player in the Inflammatory Response. The FEBS Journal, 287, 3350-3369.

[26]   Ye, Z., Wang, S., Zhang, C. and Zhao, Y. (2020) Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids. Frontiers in Endocrinology, 11, Article No. 617.

[27]   Thomas, T., Stefanoni, D., Reisz, J.A., Nemkov, T., Bertolone, L., Francis, R.O., et al. (2020) COVID-19 Infection Results in Alterations of the Kynurenine Pathway and Fatty Acid Metabolism that Correlate with IL-6 Levels and Renal Status. medRxiv.

[28]   Liu, H. and Xia, Y. (2015) Beneficial and Detrimental Role of Adenosine Signaling in Diseases and Therapy. Journal of Applied Physiology, 119, 1173-1182.

[29]   Zhang, X., Dash, R.K., Jacobs, E.R., Camara, A.K.S., Clough, A.V. and Audi, S.H. (2018) Integrated Computational Model of the Bioenergetics of Isolated Lung Mitochondria. PLoS ONE, 13, Article ID: e0197921.

[30]   Franco, R., Pugliese, A.M., Sun, Y. and Huang, P. (2016) Adenosine A 2B Receptor: From Cell Biology to Human Diseases. Frontiers in Chemistry, 1, 37,

[31]   Koukourakis, M.I. and Giatromanolaki, A. (2018) Biology Warburg Effect, Lactate Dehydrogenase and Radio/Chemo-Therapy Efficacy. International Journal of Radiation, 95, 408-426.

[32]   de Oliveira Filho, C.M., Vieceli, T., de Fraga Bassotto, C., da Rosa Barbato, J.P., Garcia, T.S. and Scheffel, R.S. (2021) Organizing Pneumonia: A Late Phase Complication of COVID-19 Responding Dramatically to Corticosteroids. The Brazilian Journal of Infectious Diseases, 25, Article ID: 101541.

[33]   Pakdemirli, E., Mandalia, U. and Monib, S. (2020) Characteristics of Chest CT Images in Patients With COVID-19 Pneumonia in London, UK. Cureus, 12, Article ID: e10289.

[34]   Guan, X., Yao, L., Tan,Y., Shen, Z., Zheng, H., Zhou, H., et al. (2021) Quantitative and Semi-Quantitative CT Assessments of Lung Lesion Burden in COVID-19 Pneumonia. Scientific Reports, 11, Article No. 5148.

[35]   Kwee, T.C. and Kwee, R.M. (2020) Chest CT in COVID-19: What the Radiologist Needs to Know. RadioGraphics, 40, 1848-1865.

[36]   Pinto-Lopes, P., Silva, A.S. and Pimenta, J. (2016) “Non-Resolving Pneumonia”: A Case of Cryptogenic Organizing Pneumonia. Porto Biomedical Journal, 1, 191-192.

[37]   Balogun, O.O., Fawole, A., Osemwinyen, E. and Balogun, B. (2021) The Placental Buffer Effect and the Pathophysiology of COVID-19: Possibilities for a Guide Aimed at Pregnant and Postpartum Women Considering Praxis: Theory, Clinical and Laboratory Observation. Journal of Infectious Diseases and Epidemiology, 7, Article No. 234.

[38]   Fredholm, B.B. (2007) Adenosine, an Endogenous Distress Signal, Modulates Tissue Damage and Repair. Cell Death & Differentiation, 14, 1315-1323.

[39]   Bowser, J.L., Lee, J.W., Yuan, X. and Eltzschig, H.K. (2017) The Hypoxia-Adenosine Link during Inflammation. Journal of Applied Physiology, 123, 1303-1320.

[40]   Escudero, C., Roberts, J.M., Myatt. L. and Feoktistov, I. (2014) Impaired Adenosine-Mediated Angiogenesis in Preeclampsia: Potential Implications for Fetal Programming. Frontiers in Pharmacology, 5, Article No. 134.

[41]   Gomes, J.I., Farinha-Ferreira, M., Rei, N., Gonçalves-Ribeiro, J., Ribeiro, J.A., Sebastião, A.M., et al. (2021) Of Adenosine and the Blues: The Adenosinergic System in the Pathophysiology and Treatment of Major Depressive Disorder. Pharmacological Research, 163, Article ID: 105363.

[42]   Borea, P.A., Gessi, S., Merighi, S., Vincenzi, F. and Varani, K. (2017) Pathological Overproduction: The Bad Side of Adenosine. British Journal of Pharmacology, 174, 1945-1960.

[43]   Barros D’Elia Zanella, L.G.F.A. and de Lima Galvão, L. (2021) The COVID-19 Burden or Tryptophan Syndrome: Autoimmunity, Immunoparalysis and Tolerance in a Tumorigenic Environment. Journal of Infectious Diseases and Epidemiology, 7, Article No. 195.

[44]   D’Elia Zanella, L.G.F. de A.B. (2022) (1) (PDF) The COVID-19 ‘Bad TryP’ Syndrome: NAD/NADH+, Tryptophan—Phenylalanine metabolism and Thermogenesis like Hecatomb—The Hypothesis of Pathophysiology Based on a Compared COVID-19 and Yellow Fever Inflammatory Skeleton. (In Press)

[45]   Barros D’Elia Zanella, L.G.F.A. (2021) NEUROCOV/PSYCCOV: Neuropsychiatric Phenomena in COVID-19—Exposing Their Hidden Essence and Warning against Iatrogenesis. Journal of Infectious Diseases and Epidemiology, 7, Article No. 222.

[46]   Sauñe, P.M., Bryce-Alberti, M., Portmann-Baracco, A.S. and Accinelli, R.A. (2020) Methylprednisolone Pulse Therapy: An Alternative Management of Severe COVID-19. Respiratory Medicine Case Reports, 31, Article ID: 101221.

[47]   Zaitsev, A.A., Golukhova, E.Z., Mamalyga, M.L., Chernov, S.A., Rybka, M.M., Kryukov, E.V., et al. (2020) Efficacy of Methylprednisolone Pulse Therapy in Patients with COVID-19. Clinical Microbiology and Antimicrobial Chemotherapy, 22, 88-91.

[48]   Ho, J.C., Ooi, G.C., Mok, T.Y., Chan, J.W., Hung, I., Lam, B., et al. (2003) High-Dose Pulse versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome. American Journal of Respiratory and Critical Care Medicine, 168, 1449-1456.

[49]   Ruiz-Irastorza, G., Pijoan, J.-I., Bereciartua, E., Dunder, S., Dominguez, J., Garcia-Escudero, P., et al. (2020) Second Week Methyl-Prednisolone Pulses Improve Prognosis in Patients with Severe Coronavirus Disease 2019 Pneumonia: An Observational Comparative Study Using Routine Care Data. PLoS ONE, 15, Articke ID: e0239401.